Series B startup

Who invested in Rain Oncology

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Funding summaryUpdated 26 Oct 2026

$63Mraised across 1 round since 2020, from 1 source

Latest round
Series B, $63MSept 2020
Investors
4
See who backed them

The rounds

  1. Sept 2020

Everyone who backed them

Perceptive AdvisorsAsset manager1round
Janus Henderson InvestorsPrivate equity1round
Cormorant Asset ManagementPrivate equity1round
Samsara BioCapitalVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Rain Oncology

Who invested in Rain Oncology?

Rain Oncology's investors include Perceptive Advisors, Janus Henderson Investors, Cormorant Asset Management and Samsara BioCapital.

How much has Rain Oncology raised?

Rain Oncology has raised $63M across 1 round since 2020.

When did Rain Oncology last raise?

Rain Oncology's most recent round was a Series B of $63M in Sept 2020.

What was Rain Oncology's biggest round?

Its most recent round, $63M in Sept 2020, is also its largest on record.

Who backed Rain Oncology first?

Rain Oncology's first round on record, in Sept 2020, was backed by Perceptive Advisors, Janus Henderson Investors and Cormorant Asset Management and 1 others.

What stage is Rain Oncology at?

Rain Oncology's latest named round is a Series B, in Sept 2020.

Companies like Rain Oncology

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.